Published in J Immunol on January 15, 2000
B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol (2010) 1.77
IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest (2003) 1.31
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes. Immunology (2007) 0.91
Tumor rejection by modulation of tumor stromal fibroblasts. J Exp Med (2003) 0.91
Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent. Cancer Immunol Res (2015) 0.88
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother (2015) 0.84
Fish oil alters tamoxifen-modulated expression of mRNAs that encode genes related to differentiation, proliferation, metastasis, and immune response in rat mammary tumors. Nutr Cancer (2012) 0.77
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment. Mediators Inflamm (2015) 0.77
IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC. Clin Exp Metastasis (2003) 0.77
Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93
Immunization of normal mouse spleen cell suspensions in vitro. Science (1966) 6.47
Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique. J Exp Med (1967) 5.78
A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity. J Exp Med (1972) 3.80
Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol (2001) 3.68
An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten. J Immunol (1970) 3.63
Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. Proc Natl Acad Sci U S A (1981) 3.28
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21
Cellular events in the immune response : analysis and in vitro response of mouse spleen cell populations separated by differential flotation in albumin gradients. J Exp Med (1968) 3.12
Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med (1994) 3.02
Radioresistance of the enhancing effect of cells from carrier-immunized mice in an in vitro primary immune response. Proc Natl Acad Sci U S A (1971) 2.79
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
Immune response restoration with macrophage culture supernatants. Science (1971) 2.37
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells. J Exp Med (1973) 2.33
Separate signals for the initiation of proliferation and differentiation in the b cell response to antigen. Transplant Rev (1975) 2.32
Suppressor T cells. Transplant Rev (1975) 2.28
Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J Exp Med (1982) 2.22
Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med (1999) 2.09
Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol (1999) 1.99
Cell components in the immune response. II. Cell attachment separation of immune cells. Cell Immunol (1970) 1.94
Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73
Immunoglobulins on the surface of thymus-derived cells engaged in the initiation of a humoral immune response. J Exp Med (1971) 1.73
The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells. Eur J Immunol (1981) 1.72
Cell components in the immune response. 3. Neonatal thymectomy: restoration in culture. Cell Immunol (1970) 1.66
Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats. J Exp Med (1965) 1.63
Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol (2001) 1.63
Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol (1996) 1.60
Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med (1983) 1.56
Continuously proliferating allospecific T cells. I. Specificity of cooperation with allogeneic B cells in the humoral antibody response to sheep erythrocytes. J Exp Med (1979) 1.54
Antigen receptor molecules: inhibition by antiserum against kappa light chains. Science (1970) 1.46
The significance of T-B collaboration across haplotype barriers. Cold Spring Harb Symp Quant Biol (1977) 1.44
The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion. Immunol Rev (1988) 1.44
T cell replacing factors in the B cell response to antigen. Immunol Rev (1982) 1.44
In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol (1998) 1.43
Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice. J Exp Med (1966) 1.39
Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. J Exp Med (1977) 1.39
Cell components in the immune response. IV. Relationships and possible interactions. Cell Immunol (1970) 1.36
Symposium on in vitro studies of the immune response. II. Significance of the reaction of lymphoid cells to homologous tissue. Bacteriol Rev (1966) 1.36
Separation of helper and suppressor T lymphocytes on a ficoll velocity sedimentation gradient. J Exp Med (1976) 1.36
Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response. J Immunol (1977) 1.30
The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens. J Immunol (1975) 1.25
Production of Con A-induced helper T cell replacing factor requires a T cell and an Ia-positive non-T cells. J Immunol (1980) 1.23
Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J Exp Med (1971) 1.23
In vitro studies of immunological responses of lymphoid cells. Adv Immunol (1967) 1.20
Stimulation of DNA synthesis in cultures of mouse spleen cell suspensions by bovine transferrin. Exp Cell Res (1969) 1.18
B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Exp Med (1987) 1.17
Analysis of histocompatibility requirements for proliferative and helper T cell activity. T cell populations depleted of alloreactive cells by negative selection. J Exp Med (1980) 1.14
Partial purification and characterization of a BCGFII from EL4 culture supernatants. J Immunol (1984) 1.13
Alloantigen-induced T helper activity. I. Minimal genetic differences necessary to induce a positive allogeneic effect. J Immunol (1978) 1.10
Ly phenotypes and MHC recognition: the allohelper that recognizes K or D is a mature Ly123 cell. J Immunol (1979) 1.06
Fine specificity mapping of two allospecific T cell lines: recognition of private specificities in the H-2 IA subregion. Eur J Immunol (1981) 1.04
Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. J Immunol (1999) 1.03
Competition between concanavalin A-induced stimulatory and inhibitory effects in the in vitro immune response to antigen. J Exp Med (1975) 1.02
Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. J Immunol (2001) 1.01
Evidence for two distinct activation states available to B lymphocytes. J Immunol (1984) 0.98
Evidence that Con A induces cytotoxicity in the same subclass of T cells as does alloimmunization. J Immunol (1977) 0.98
Improving geometric model construction for blood flow modeling. IEEE Eng Med Biol Mag (1999) 0.97
Regulation of the immune response T-cell interactions. CRC Crit Rev Immunol (1982) 0.96
CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J Immunol (1999) 0.96
Alloreactivity, the development of the T cell repertoire and the understanding of T cell function. Immunol Rev (1978) 0.95
Cellular cooperation in hapten-carrier responses in the newt, Triturus viridescens. Cell Immunol (1973) 0.94
Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol (1995) 0.93
Cell components in the immune response. I. Gradient separation of immune cells. Cell Immunol (1970) 0.93
The humoral response of mouse spleen cells to two types of sheep erythrocytes. I. Genetic control of the response to H and L SRBC. J Immunol (1975) 0.91
Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection. Clin Immunol (2001) 0.91
The humoral response of mouse spleen cells to two types of sheep erythrocytes. III. A new VH region marker. J Immunol (1975) 0.91
Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5). J Immunol (1987) 0.90
A monoclonal T cell-replacing activity can act directly on B cells to enhance clonal expansion. J Exp Med (1982) 0.89
Negative allogeneic effects in vitro. II. Mapping of histocompatibility differences leading to allosuppression. J Immunol (1977) 0.89
Consequences of the direct interaction of helper T cells with B cells presenting antigen. Immunol Rev (1987) 0.89
Frequency of allogeneic helper T cells responding to whole H-2 differences and to an H-2K difference alone. J Immunol (1979) 0.87
Antigen suppression of the in vitro development of plaque-forming cells to autologous erythrocyte antigens. J Immunol (1975) 0.86
Role of antigen in the B cell response. Specific antigen and the lymphokine IL-5 synergize to drive B cell lymphoma proliferation and differentiation to Ig secretion. J Immunol (1988) 0.86
Characterization of the target antigen of F1 anti-parent cytotoxic lympholysis: analysis of the spontaneous in vitro F1 cytotoxic T lymphocytes. J Immunol (1980) 0.85
Induction of the H-2 D antigen during B cell activation. J Immunol (1989) 0.84
Precursor cell division during the immune response in vitro: antigen-induced and "spontaneous" antibody-forming cells. Eur J Immunol (1973) 0.84
Suppressor T cells in the regulation of the immune response. J Reticuloendothel Soc (1975) 0.83
Separation of helper and suppressor T lymphocytes. III. Positive and negative effects of mixed lymphocyte reaction-activated T cells. J Immunol (1978) 0.82
Primary in vitro cytotoxic response of F1 T lymphocytes against parental antigens. J Immunol (1979) 0.82
Independent analysis of T helper and T killer cell function in young and old NZB mice. J Immunol (1978) 0.82
Role of T cells in the B-cell response: glutaraldehyde-fixed T-helper hybridoma cells synergize with the lymphokine IL-4 to induce B-cell activation and proliferation. Immunology (1991) 0.81
Monoclonal antibody that distinguishes between a phosphorylated, beta 2-microglobulin-associated, and a free, nonphosphorylated, chain of MHC class I. J Immunol (1993) 0.81
Presence of host-reactive T cells in lymphohaematopoietic chimeras. Immunology (1983) 0.81
The effects of prolonged administration of 5-bromodeoxyuridine on cells of the immune system. J Immunol (2000) 0.80
Cloning and sequencing of a trophoblast-endothelial-activated lymphocyte surface protein: cDNA sequence and genomic structure. Proc Natl Acad Sci U S A (1992) 0.79
Expression of an endothelial surface antigen on activated human lymphocytes: lymphocyte subset distribution and kinetics of antigen activation. Cell Immunol (1987) 0.78
Lymphocytic proliferation in response to homologous tissue antigens. Fed Proc (1967) 0.77
Partial purification and characterization of a factor from a cloned thymic epithelium cell line. J Immunol (1986) 0.77
Young F mice spontaneously generate cytotoxic T cells against parental targets. J Immunol (1979) 0.77
The humoral immune response of mouse bone marrow lymphocytes in vitro. Immunology (1977) 0.75
B cell surface glycoprotein induced during growth response: molecular structure and expression pattern. J Immunol (1987) 0.75